Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)
Crossref DOI link: https://doi.org/10.1007/s00280-014-2427-7
Published Online: 2014-05-24
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pillai, Rathi N.
Aisner, Joseph
Dahlberg, Suzanne E.
Rogers, John S.
DiPaola, Robert S.
Aisner, Seena
Ramalingam, Suresh S.
Schiller, Joan H.
Text and Data Mining valid from 2014-05-24